12月23日，安琪酵母盘中下跌2.06%，截至11:14，报44.66元/股，成交2.65亿元，换手率0.69%，总市值 387.67亿元。 资金流向方面，主力资金净流出3151.17万元，特大单买入1197.44万元，占比4.51%，卖出2859.71万 元，占比10.78%；大单买入3624.80万元，占比13.66%，卖出5113.71万元，占比19.28%。 安琪酵母今年以来股价涨25.80%，近5个交易日涨10.00%，近20日涨10.24%，近60日涨13.75%。 今年以来安琪酵母已经1次登上龙虎榜，最近一次登上龙虎榜为3月5日，当日龙虎榜净买入-1.36亿元； 买入总计1.88亿元 ，占总成交额比19.17%；卖出总计3.24亿元 ，占总成交额比33.09%。 资料显示，安琪酵母股份有限公司位于湖北省宜昌市城东大道168号，成立日期1998年3月25日，上市日 期2000年8月18日，公司主营业务涉及从事酵母、酵母衍生物及相关生物制品的开发、生产和经营。主 营业务收入构成为：酵母及相关行业90.62%，其他7.89%，包装物4.07%。 安琪酵母所属申万行业为：食品饮料-调味发酵品Ⅱ-调味发酵 ...

Core Viewpoint - The stock of China Three Gorges Tourism has shown significant growth, with a year-to-date increase of 61.02% and a recent surge of 18.71% over the past five trading days, indicating strong market interest and performance [1][3]. Company Overview - China Three Gorges Tourism Group Co., Ltd. is located in Yichang, Hubei Province, and was established on August 10, 1998, with its stock listed on November 3, 2011 [2]. - The company's main business includes passenger transport, tourism services, domestic express delivery, insurance agency, and various other services related to tourism and transportation [2]. Revenue Composition - The revenue structure of the company is as follows: - Tourism comprehensive services: 34.47% - Comprehensive transportation services: 21.36% - Travel agency business: 15.80% - Sightseeing cruise services: 12.18% - Other segments include logistics, vehicle services, and tourism port services [2]. Stock Performance and Market Activity - As of December 18, the stock price was 7.93 yuan per share, with a trading volume of 2.76 billion yuan and a market capitalization of 57.46 billion yuan [1]. - The stock has experienced a net outflow of 21.24 million yuan in principal funds, with significant buying and selling activity from large orders [1]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 609 million yuan, reflecting a year-on-year growth of 9.48%, while the net profit attributable to shareholders decreased by 23.29% to 85.87 million yuan [3]. Shareholder Information - As of December 10, the number of shareholders was 20,700, a decrease of 14.74%, with an average of 34,606 circulating shares per shareholder, an increase of 17.29% [3]. - The company has distributed a total of 508 million yuan in dividends since its A-share listing, with 138 million yuan distributed in the last three years [4]. Institutional Holdings - As of September 30, 2025, notable institutional shareholders include Penghua Quality Governance Mixed Fund, which is the fourth largest shareholder, and two other new institutional investors in the top ten [4].

资金流向方面，主力资金净流入76.43万元，大单买入173.86万元，占比11.79%，卖出97.43万元，占比 6.61%。 国创高新今年以来股价跌12.69%，近5个交易日跌0.69%，近20日跌8.25%，近60日跌7.37%。 资料显示，湖北国创高新材料股份有限公司位于湖北省武汉市东湖新技术开发区武大园三路8号，成立 日期2002年3月25日，上市日期2010年3月23日，公司主营业务涉及改性沥青产品的开发、生产与销售。 房地产中介服务。主营业务收入构成为：重交沥青75.75%，改性沥青18.81%，道路工程施工及养护 2.63%，改性沥青加工1.72%，其他产品0.77%，乳化沥青0.34%。 12月18日，国创高新盘中上涨2.12%，截至10:23，报2.89元/股，成交1474.46万元，换手率0.59%，总市 值26.48亿元。 国创高新所属申万行业为：石油石化-炼化及贸易-其他石化。所属概念板块包括：微盘股、低价、小 盘、沥青概念、湖北自贸区等。 截至11月28日，国创高新股东户数2.75万，较上期减少6.46%；人均流通股31721股，较上期增加 6.91%。2025年1月-9月，国创高新 ...

Core Viewpoint - The stock of Fenghuo Communication has shown a significant increase in price and trading activity, indicating positive market sentiment despite a decline in revenue for the year [1][2]. Company Performance - As of December 1, Fenghuo Communication's stock price rose by 2.01% to 23.32 CNY per share, with a total market capitalization of 30.05 billion CNY [1]. - The company has experienced a year-to-date stock price increase of 20.95%, with a recent 5-day increase of 5.57%, but a decline of 3.95% over the last 20 days and 14.98% over the last 60 days [1]. - For the period from January to September 2025, Fenghuo Communication reported a revenue of 17.072 billion CNY, a year-on-year decrease of 19.30%, while the net profit attributable to shareholders increased by 30.28% to 513 million CNY [2]. Shareholder Information - As of September 30, 2025, the number of shareholders for Fenghuo Communication was 119,300, a decrease of 6.90% from the previous period, with an average of 9,928 circulating shares per shareholder, an increase of 9.08% [2]. - The company has distributed a total of 3.791 billion CNY in dividends since its A-share listing, with 494 million CNY distributed over the last three years [3]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the second-largest circulating shareholder, holding 21.3305 million shares, an increase of 5.5716 million shares from the previous period [3]. - The Southern CSI 500 ETF ranked as the fourth-largest circulating shareholder with 11.1020 million shares, an increase of 0.5396 million shares [3].

资料显示，武汉农尚环境股份有限公司位于湖北省武汉市江岸区健康街66号绿地·汉口中心(二期)S11号 楼27层办公(7)室-办公(9)室，成立日期2000年4月28日，上市日期2016年9月20日，公司主营业务涉及园 林绿化工程设计、施工、养护及苗木培育业务。主营业务收入构成为：算力综合服务86.91%，园林绿 化工程11.07%，其他2.02%。 农尚环境所属申万行业为：建筑装饰-基础建设-园林工程。所属概念板块包括：湖北自贸区、集成电 路、新型城镇化、PPP概念、算力概念等。 11月27日，农尚环境（维权）盘中上涨2.10%，截至09:53，报8.27元/股，成交932.23万元，换手率 0.39%，总市值24.25亿元。 资金流向方面，主力资金净流入6.97万元，大单买入29.03万元，占比3.11%，卖出22.06万元，占比 2.37%。 农尚环境今年以来股价涨44.33%，近5个交易日跌2.01%，近20日跌2.71%，近60日跌22.05%。 分红方面，农尚环境A股上市后累计派现4380.86万元。近三年，累计派现0.00元。 责任编辑：小浪快报 截至11月10日，农尚环境股东户数1.20万，较上期 ...

Core Viewpoint - Aerospace Electronics experienced a decline of 2.02% in stock price, with a current price of 10.67 CNY per share and a total market capitalization of 35.204 billion CNY [1] Financial Performance - For the period from January to September 2025, Aerospace Electronics reported a revenue of 8.835 billion CNY, a year-on-year decrease of 4.32%, and a net profit attributable to shareholders of 209 million CNY, down 62.77% year-on-year [2] - The company has cumulatively distributed 1.124 billion CNY in dividends since its A-share listing, with 514 million CNY distributed in the last three years [3] Stock Market Activity - As of November 26, 2025, the stock has increased by 19.75% year-to-date, but has seen a decline of 0.65% over the last five trading days, 9.73% over the last 20 days, and 8.96% over the last 60 days [1] - The stock's trading volume on November 26 was 390 million CNY, with a turnover rate of 1.09% [1] Shareholder Information - As of September 30, 2025, the number of shareholders increased to 156,000, with an average of 21,145 circulating shares per shareholder, a decrease of 1.04% from the previous period [2] - Major institutional shareholders include E Fund Defense Industry Mixed A and Fortune China Securities Military Industry Leader ETF, with significant increases in their holdings [3]

Core Viewpoint - Renfu Pharmaceutical's stock price has shown a decline of 14.79% year-to-date, with recent trading activity indicating a slight recovery, as the stock rose by 2.08% on November 26, 2023 [1] Financial Performance - For the period from January to September 2025, Renfu Pharmaceutical reported a revenue of 17.883 billion yuan, representing a year-on-year decrease of 6.58%. However, the net profit attributable to shareholders increased by 6.22% to 1.689 billion yuan [2] - Cumulative cash dividends paid by Renfu Pharmaceutical since its A-share listing amount to 3.113 billion yuan, with 1.779 billion yuan distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders for Renfu Pharmaceutical reached 69,400, an increase of 38.71% from the previous period. The average number of circulating shares per person decreased by 27.91% to 22,222 shares [2] - Among the top ten circulating shareholders, Hong Kong Central Clearing Limited holds 42.1832 million shares, a decrease of 1.3907 million shares compared to the previous period [3]

Group 1 - The core viewpoint of the news is that Sely Medical has experienced significant stock price fluctuations, with a year-to-date increase of 191.14% but a recent decline of 33.31% over the past 60 days [1] - As of November 24, Sely Medical's stock price is 21.02 CNY per share, with a total market capitalization of 4.418 billion CNY [1] - The company has seen a net inflow of main funds amounting to 4.0757 million CNY, with significant trading activity reflected in the buying and selling of large orders [1] Group 2 - Sely Medical, established on February 23, 2004, and listed on October 31, 2016, is primarily engaged in medical testing marketing and services, as well as the research, production, and sales of in vitro diagnostic products [2] - The company's revenue composition includes 39.91% from IVD business, 38.01% from SPD business, and 22.08% from pure sales [2] - As of September 30, the company reported a revenue of 857 million CNY for the first nine months of 2025, a year-on-year decrease of 39.64%, and a net profit loss of 87.2441 million CNY, down 55.72% year-on-year [2] Group 3 - Since its A-share listing, Sely Medical has distributed a total of 27.0741 million CNY in dividends, with no dividends paid in the last three years [3] - As of September 30, 2025, the top ten circulating shareholders include several new institutional investors, indicating a shift in shareholder composition [3]

Core Viewpoint - The stock of Fenghuo Communication has shown fluctuations, with a year-to-date increase of 14.36% but a recent decline over various trading periods, indicating potential volatility in the market [1][2]. Company Overview - Fenghuo Communication, established on December 25, 1999, and listed on August 23, 2001, is located in Wuhan, Hubei Province. The company specializes in the research, production, and sales of network information security products and mobile information products [1]. - The main revenue composition includes: 78.51% from communication system equipment, 18.02% from optical fiber cables, 1.98% from data network products, and 1.49% from other sources [1]. Financial Performance - For the period from January to September 2025, Fenghuo Communication reported a revenue of 17.072 billion, a year-on-year decrease of 19.30%. However, the net profit attributable to shareholders increased by 30.28% to 513 million [2]. - The company has distributed a total of 3.791 billion in dividends since its A-share listing, with 494 million distributed over the past three years [3]. Shareholder Information - As of September 30, 2025, the number of shareholders decreased by 6.90% to 119,300, while the average circulating shares per person increased by 9.08% to 9,928 shares [2]. - The top circulating shareholders include Hong Kong Central Clearing Limited, which increased its holdings by 5.5716 million shares to 21.3305 million shares, and Southern CSI 500 ETF, which increased its holdings by 539,600 shares to 11.102 million shares [3].

Core Viewpoint - The stock of Jia Bi You experienced a decline of 2.04% on November 21, with a current price of 23.04 CNY per share, reflecting a significant drop in recent trading days [1] Company Overview - Jia Bi You Biotechnology (Wuhan) Co., Ltd. was established on September 22, 2004, and went public on December 19, 2019. The company specializes in the research, production, and sales of polyunsaturated fatty acids such as ARA and DHA, as well as natural β-carotene, with applications in infant formula, dietary supplements, and special medical foods [2] - The revenue composition of Jia Bi You includes ARA products at 76.16%, DHA products at 21.24%, and other supplements at 2.60% [2] - The company is classified under the basic chemical industry, specifically in chemical products related to food and feed additives, and is associated with concepts such as pet economy, synthetic biology, cosmetics, multiple births, and Hubei Free Trade Zone [2] Financial Performance - For the period from January to September 2025, Jia Bi You achieved a revenue of 428 million CNY, representing a year-on-year growth of 10.56%. The net profit attributable to the parent company was 129 million CNY, showing a significant increase of 54.18% [2] - Since its A-share listing, Jia Bi You has distributed a total of 243 million CNY in dividends, with 103 million CNY distributed over the past three years [3] Shareholder Information - As of September 30, 2025, the number of shareholders for Jia Bi You was 8,362, an increase of 1.01% from the previous period, while the average circulating shares per person decreased by 1.00% to 20,127 shares [2] - Notably, several institutional investors, including 华夏稳增混合 and 鹏华优质治理混合(LOF)A, have exited the list of the top ten circulating shareholders [3]